|
Q2 FY2027
As of Aug 31, 2026
|
Q1 FY2027
As of May 31, 2026
|
Q4 FY2026
As of Feb 28, 2026
|
Q3 FY2026
As of Nov 30, 2025
|
Q2 FY2026
As of Aug 31, 2025
|
Q1 FY2026
As of May 31, 2025
|
Q4 FY2025
As of Feb 28, 2025
|
Q3 FY2025
As of Nov 30, 2024
|
Q2 FY2025
As of Aug 31, 2024
|
Q1 FY2025
As of May 31, 2024
|
Q4 FY2024
As of Feb 29, 2024
|
Q3 FY2024
As of Nov 30, 2023
|
Q2 FY2024
As of Aug 31, 2023
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | |||||||||||||
| Cash | |||||||||||||
| Other Receivable | |||||||||||||
| Account Receivable | |||||||||||||
| Prepaid Expenses | |||||||||||||
| Total Current Assets | |||||||||||||
| Intangible/Other/Software Technology Assets, Net | |||||||||||||
| TOTAL ASSETS | |||||||||||||
| Current Liabilities | |||||||||||||
| Accounts Payable | |||||||||||||
| Deferred Revenue | |||||||||||||
| Related Party Loan | |||||||||||||
| Total Current Liabilities | |||||||||||||
| Stockholders’ Equity (Deficit) | |||||||||||||
| Common Stock, $0.001 par value, 75,000,000 shares authorized, 22,962,640 and 17,962,640 shares issued and outstanding as of August 31, 2026, and February 28, 2026, respectively | |||||||||||||
| Additional Paid-In Capital | |||||||||||||
| Accumulated Deficit | |||||||||||||
| Total Stockholders’ Equity (Deficit) | |||||||||||||
| TOTAL LIABILITIES & STOCKHOLDERS’ EQUITY (DEFICIT) | |||||||||||||
Loading...
